UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials

Journal of neurology, 2024-05, Vol.271 (5), p.2914-2916

2024

Volltextzugriff (PDF)

Imaging and CSF analyses effectively distinguish CJD from its mimics

Journal of neurology, neurosurgery and psychiatry, 2018-05, Vol.89 (5), p.461-466

2018

Volltextzugriff (PDF)

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial

Lancet neurology, 2009-04, Vol.8 (4), p.334-344

2009

Volltextzugriff (PDF)

Infratentorial superficial siderosis: Classification, diagnostic criteria, and rational investigation pathway

Annals of neurology, 2017-03, Vol.81 (3), p.333-343

2017

Volltextzugriff (PDF)

Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease

Journal of neurology, neurosurgery and psychiatry, 2015-06, Vol.86 (6), p.692-694

2015

Volltextzugriff (PDF)

Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort Study

Movement disorders, 2022-09, Vol.37 (9), p.1893-1903

2022

Volltextzugriff (PDF)

Assessing initial MRI reports for suspected CJD patients

Journal of neurology, 2022-08, Vol.269 (8), p.4452-4458

2022

Volltextzugriff (PDF)

Cognitive decline heralds onset of symptomatic inherited prion disease

Brain (London, England : 1878), 2021-04, Vol.144 (3), p.989-998

2021

Volltextzugriff (PDF)

Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease

Brain (London, England : 1878), 2019-03, Vol.142 (3), p.760-770

2019

Volltextzugriff (PDF)

Transmissibility of Alzheimer’s? Evidence from recipients of human growth hormone

The Neuroscientist (Baltimore, Md.), 2024-08, Vol.30 (4), p.397-397

2024

Volltextzugriff (PDF)

Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease

JAMA neurology, 2016-04, Vol.73 (4), p.447

2016

Volltextzugriff (PDF)

The Medical Research Council Prion Disease Rating Scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies

Brain (London, England : 1878), 2013-04, Vol.136 (Pt 4), p.1116-1127

2013

Volltextzugriff (PDF)

Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years

Brain (London, England : 1878), 2015-11, Vol.138 (Pt 11), p.3386-3399

2015

Volltextzugriff (PDF)

High-b-Value Diffusion MR Imaging and Basal Nuclei Apparent Diffusion Coefficient Measurements in Variant and Sporadic Creutzfeldt-Jakob Disease

American journal of neuroradiology : AJNR, 2010-03, Vol.31 (3), p.521-526

2010

Volltextzugriff (PDF)

Immunotherapy-responsive seizure-like episodes with potassium channel antibodies

Neurology, 2008-11, Vol.71 (20), p.1647-1648

2008

Volltextzugriff (PDF)

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Acta neuropathologica, 2021-07, Vol.142 (1), p.211-215

2021

Volltextzugriff (PDF)

The Tullio phenomenon: a neurologically neglected presentation

Journal of neurology, 2012, Vol.259 (1), p.4-21

2012

Volltextzugriff (PDF)

Tau, prions and Aβ: the triad of neurodegeneration

Acta neuropathologica, 2011-01, Vol.121 (1), p.5-20

2011

Volltextzugriff (PDF)

MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease

BMC neurology, 2012-12, Vol.12 (1), p.153-153, Article 153

2012

Volltextzugriff (PDF)

Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation

JAMA neurology, 2016-01, Vol.73 (1), p.76

2016

Volltextzugriff (PDF)

Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob disease

Journal of neurology, neurosurgery and psychiatry, 2022-04, Vol.93 (4), p.404-412

2022

Volltextzugriff (PDF)

Lymphomatosis cerebri presenting as a rapidly progressive dementia with a high methylmalonic acid

Journal of neurology, 2011-08, Vol.258 (8), p.1489-1493

2011

Volltextzugriff (PDF)

Pelvic floor muscle training for women with lumbopelvic pain: A systematic review and meta‐analysis

European journal of pain, 2020-11, Vol.24 (10), p.1865-1879

2020

Volltextzugriff (PDF)

Neurological complications in Behçet's syndrome

Brain (London, England : 1878), 1999-11, Vol.122 ( Pt 11) (11), p.2183-2183

1999

Volltextzugriff (PDF)

Autoantibodies in sporadic Creutzfeldt-Jakob disease

JAMA neurology, 2013-07, Vol.70 (7), p.919

2013

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

ThemaClinical Neurology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(107)

Publikationsform

Artikel
(127)

Sprache

Englisch
(127)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Amyloid antibody therapy for early-stage Alzheimer’s disease: a critical review of three recent trials

Imaging and CSF analyses effectively distinguish CJD from its mimics

Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial

Infratentorial superficial siderosis: Classification, diagnostic criteria, and rational investigation pathway

Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob disease

Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort Study

Assessing initial MRI reports for suspected CJD patients

Cognitive decline heralds onset of symptomatic inherited prion disease

Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease

Transmissibility of Alzheimer’s? Evidence from recipients of human growth hormone

Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease

The Medical Research Council Prion Disease Rating Scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies

Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years

High-b-Value Diffusion MR Imaging and Basal Nuclei Apparent Diffusion Coefficient Measurements in Variant and Sporadic Creutzfeldt-Jakob Disease

Immunotherapy-responsive seizure-like episodes with potassium channel antibodies

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

The Tullio phenomenon: a neurologically neglected presentation

Tau, prions and Aβ: the triad of neurodegeneration

MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease

Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation

Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob disease

Lymphomatosis cerebri presenting as a rapidly progressive dementia with a high methylmalonic acid

Pelvic floor muscle training for women with lumbopelvic pain: A systematic review and meta‐analysis

Neurological complications in Behçet's syndrome

Autoantibodies in sporadic Creutzfeldt-Jakob disease

Aktive Filter

Suchergebnisse filtern